Is the elimination of ‘sleeping sickness’ affordable? Who will pay the price? Assessing the financial burden for the elimination of human African trypanosomiasis Trypanosoma brucei gambiense in sub-Saharan Africa
Introduction Programme to eliminate neglected tropical diseases (NTDs) have gained global recognition, and may allow for improvements to universal health coverage and poverty alleviation. It is hoped that elimination of human African trypanosomiasis (HAT) Trypanosoma brucei gambiense (Tbg) would ass...
Saved in:
| Main Authors: | C Simone Sutherland, Fabrizio Tediosi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2019-03-01
|
| Series: | BMJ Global Health |
| Online Access: | https://gh.bmj.com/content/4/2/e001173.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The genome sequence of Trypanosoma brucei gambiense, causative agent of chronic human african trypanosomiasis.
by: Andrew P Jackson, et al.
Published: (2010-04-01) -
Monitoring the Progress towards the Elimination of Gambiense Human African Trypanosomiasis.
by: Pere P Simarro, et al.
Published: (2015-01-01) -
Health economic evaluation of strategies to eliminate gambiense human African trypanosomiasis in the Mandoul disease focus of Chad.
by: Marina Antillon, et al.
Published: (2023-07-01) -
Towards the sustainable elimination of gambiense human African trypanosomiasis in Côte d'Ivoire using an integrated approach.
by: Dramane Kaba, et al.
Published: (2023-07-01) -
The TgsGP gene is essential for resistance to human serum in Trypanosoma brucei gambiense.
by: Paul Capewell, et al.
Published: (2013-01-01)